Figure 9.
Comparison of in vivo and CFD predictions of DF in different regions of the airways for the Respimat inhaler with a fenoterol formulation considering one SIP geometry in each lung lobe. As with the LL lobe approximation, agreement is again achieved between the in vivo data and model predictions by considering one SIP geometry extending into each lung lobe.